Literature DB >> 11709458

Osteonecrosis in patients with systemic lupus erythematosus develops very early after starting high dose corticosteroid treatment.

K Oinuma1, Y Harada, Y Nawata, K Takabayashi, I Abe, K Kamikawa, H Moriya.   

Abstract

OBJECTIVES: To investigate the actual time of onset of osteonecrosis (ON) after high dose corticosteroid treatment in systemic lupus erythematosus (SLE).
METHODS: 72 patients with active SLE, who received high dose corticosteroid for the first time, for the development of ON at hips and knees were monitored by magnetic resonance imaging for at least 12 months.
RESULTS: ON lesions were detected in 32/72 patients (44%) between one and five months (3.1 months on average) after starting high dose corticosteroid treatment. No osteonecrotic lesion was newly detected from the sixth month of treatment until the end of the follow up period.
CONCLUSION: The findings suggested that the actual time of onset of ON in SLE is within the first month of high dose corticosteroid treatment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11709458      PMCID: PMC1753447          DOI: 10.1136/ard.60.12.1145

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  43 in total

Review 1.  Clinical characteristics of avascular necrosis in patients with Behçet disease: a case series and literature review.

Authors:  Nuh Atas; Berivan Bitik; Ozkan Varan; Hakan Babaoglu; Abdurrahman Tufan; Seminur Haznedaroglu; Berna Goker; Mehmet Akif Ozturk
Journal:  Rheumatol Int       Date:  2018-12-17       Impact factor: 2.631

Review 2.  Steroid induced osteonecrosis: An analysis of steroid dosing risk.

Authors:  Christian Powell; Christopher Chang; Stanley M Naguwa; Gurtej Cheema; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2010-07-09       Impact factor: 9.754

Review 3.  MRI-detected bone marrow changes within 3 weeks after initiation of high-dose corticosteroid therapy: a possible change preceding the subsequent appearance of low-intensity band in femoral head osteonecrosis.

Authors:  Yusuke Kubo; Takuaki Yamamoto; Goro Motomura; Nobuaki Tsukamoto; Kazuyuki Karasuyama; Kazuhiko Sonoda; Hiroyuki Hatanaka; Takeshi Utsunomiya; Yukihide Iwamoto
Journal:  Rheumatol Int       Date:  2015-08-22       Impact factor: 2.631

4.  Cytochrome P4503A activity affects the gender difference in the development of steroid-induced osteonecrosis in rabbits.

Authors:  Satoshi Ikemura; Takuaki Yamamoto; Goro Motomura; Ryosuke Yamaguchi; Garida Zhao; Kenyu Iwasaki; Yukihide Iwamoto
Journal:  Int J Exp Pathol       Date:  2013-10-29       Impact factor: 1.925

5.  High risk of osteonecrosis of the femoral head in autoimmune disease patients showing no immediate increase in hepatic enzyme under steroid therapy.

Authors:  Shunichiro Okazaki; Satoshi Nagoya; Motohisa Yamamoto; Kenji Tateda; Hiroki Takahashi; Toshihiko Yamashita; Hiroshi Matsumoto
Journal:  Rheumatol Int       Date:  2012-01-04       Impact factor: 2.631

6.  The risk benefit ratio of glucocorticoids in SLE: have things changed over the past 40 years?

Authors:  G Stojan; M Petri
Journal:  Curr Treatm Opt Rheumatol       Date:  2017-07-27

7.  Systemic lupus erythematosus patients with high disease activity are associated with accelerated incidence of osteonecrosis: a systematic review and meta-analysis.

Authors:  Kui Zhang; Yan Zheng; Junfeng Jia; Jin Ding; Zhenbiao Wu
Journal:  Clin Rheumatol       Date:  2017-09-25       Impact factor: 2.980

8.  The risk factors of avascular necrosis in patients with systemic lupus erythematosus: a meta-analysis.

Authors:  Kao-Kao Zhu; Wang-Dong Xu; Hai-Feng Pan; Min Zhang; Jing Ni; Fu-Yang Ge; Dong-Qing Ye
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

9.  Symptomatic knee osteonecrosis in patients with systemic lupus erythematosus: a case-control study.

Authors:  Lidan Zhao; Xiuhua Wu; Honghua Wu; Jinmei Su; Wen Zhang; Yan Zhao; Xuan Zhang; Wenjie Zheng
Journal:  Rheumatol Int       Date:  2016-05-26       Impact factor: 2.631

10.  The use of joint-specific and whole-body MRI in osteonecrosis: a study in patients with juvenile systemic lupus erythematosus.

Authors:  T C M Castro; H Lederman; M T A Terreri; W I Caldana; S C Kaste; M O Hilário
Journal:  Br J Radiol       Date:  2010-11-16       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.